![Carter Cliff](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Carter Cliff is the founder of Dianomi Therapeutics, Inc., founded in 2017.
Mr. Cliff is also the founder of Opsis Therapeutics LLC,Vascugen, Inc...
Mr. Cliff currently holds the position of President, Chief Executive Officer & Director at Tacitus Therapeutics, Inc., starting in 2019.
| Bedrijven | Functie | Begin |
|---|---|---|
Tacitus Therapeutics, Inc.
 Tacitus Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops stem cell therapies for life-threatening diseases | Algemeen Directeur | - |
Vascugen, Inc.
 Vascugen, Inc. BiotechnologyHealth Technology Provides biotechnology services | Oprichter | - |
| Bedrijven | Functie | Einde |
|---|---|---|
Opsis Therapeutics LLC
 Opsis Therapeutics LLC Pharmaceuticals: MajorHealth Technology Develops medicines for retinal diseases | Oprichter | - |
Dianomi Therapeutics, Inc.
 Dianomi Therapeutics, Inc. BiotechnologyHealth Technology Operates as biopharmaceutical company, develops next generation therapeutics for autoimmune diseases | Oprichter | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
| Bedrijven in privébezit | 4 |
|---|---|
Dianomi Therapeutics, Inc.
Dianomi Therapeutics, Inc. BiotechnologyHealth Technology Operates as biopharmaceutical company, develops next generation therapeutics for autoimmune diseases | Health Technology |
Vascugen, Inc.
Vascugen, Inc. BiotechnologyHealth Technology Provides biotechnology services | Health Technology |
Tacitus Therapeutics, Inc.
Tacitus Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops stem cell therapies for life-threatening diseases | Commercial Services |
Opsis Therapeutics LLC
Opsis Therapeutics LLC Pharmaceuticals: MajorHealth Technology Develops medicines for retinal diseases | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau
Kies MarketScreener 
